Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Flows From Operating Activities:
Net loss	$ (5,367,224)	$ (5,964,823)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	21,740	80,000
Depreciation	63,492	10,570
Amortization of patents	503,340	503,340
Changes in operating assets and liabilities
Settlement receivable	52,500	434,040
Prepaid expenses	201,096	192,643
Accounts payable - trade	(1,966,372)	(810,036)
Other accrued expenses and lease liability	371,776	462,409
Accrued interest expense	1,068,600	697,214
Net Cash Used In Operating Activities	(5,051,052)	(4,394,643)
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	5,235,000	2,556,000
Proceeds from issuance of convertible notes payable - related parties	25,000	1,350,000
Proceeds from exercise of warrants	199,654	615,059
Net Cash Provided By Financing Activities	5,459,654	4,521,059
Effect of Exchange Rate Changes on Cash	(24,801)
Net Increase In Cash and Cash Equivalents	383,801	126,416
Cash and Cash Equivalents, Beginning of Period	50,986	105,504
Cash and Cash Equivalents, End of Period	434,787	231,920
Supplemental Disclosures of Cash Flow Information:
Interest
Taxes
Non-cash investing and financing activities:
Offset of related party receivable and payable	$ 252,750